Perfusion Clinical Solutions LLC is categorized under Medical Labs in Saint Petersburg, FL and active since 2010.
Perfusion Clinical Solutions LLC was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Todd Carl at the company’s single location by writing to 3817 19th Avenue North, Saint Petersburg, Florida FL 33713 or by phoning (727) 327-7613. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Perfusion Clinical Solutions LLC |
| Contact Person: | Todd Carl |
| Address: | 3817 19th Avenue North, Saint Petersburg, Florida 33713 |
| Phone Number: | (727) 327-7613 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Perfusion Clinical Solutions LLC was started in 2010 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Todd Carl for inquiries that concern Perfusion Clinical Solutions LLC by calling the company number (727) 327-7613, as your correspondence is most welcome. Additionally, the physical location of the single location of Perfusion Clinical Solutions LLC can be found at the coordinates 27.789796,-82.685324 as well as the street address 3817 19th Avenue North in Saint Petersburg, Florida 33713.
For its online presence, you may visit Perfusion Clinical Solutions LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.